Published in Ned Tijdschr Geneeskd on August 05, 1972
Effects of glucocorticosteroids on primary human skin fibroblasts. I. Inhibition of the proliferation of cultured primary human skin and mouse L929 fibroblasts. Arch Dermatol Res (1977) 1.04
Xanthomatosis and hyperlipoproteinemia; a review. Dermatologica (1974) 1.04
Dependence of corticosteroid penetration on the vehicle. Arch Dermatol (1976) 1.01
Difference in the efficiency of two delivery forms of 8-methoxypsoralen. Dermatologica (1977) 0.92
Primary hyperlipoproteinemia: the clinico-chemical classification of the most common types. Clin Chim Acta (1968) 0.89
Factors influencing the penetration of corticosteroids through the epidermis. Adv Biol Skin (1972) 0.87
[Clinical and biochemical aspects of the xanthomatoses]. Hautarzt (1966) 0.82
Effects of glucocorticosteroids on cultured human skin fibroblasts. III. Transient inhibition of cell proliferation in the early growth stages and reduced susceptibility in later growth stages. Arch Dermatol Res (1979) 0.82
[Assessment of value and risks of external treatment with clobetasol-17-propionate (Dermovate)]. Ned Tijdschr Geneeskd (1978) 0.81
Bleomycin therapy in mycosis fungoides. Dermatologica (1975) 0.80
Penetration of various corticosteroids through epidermis in vitro. Arch Dermatol Res (1979) 0.79
Pemphigus benignus familiaris (with special reference to the histopathological diagnosis). Dermatologica (1967) 0.78
Is the use of Ro 10-9359 (Tigason) in children justified? Acta Derm Venereol (1980) 0.78
Cutaneous xanthomatosis in relation to the blood lipoprotein pattern. Br J Dermatol (1969) 0.77
A clinical trial with hydrocortisone butyrate cream in psoriasis. Br J Dermatol (1970) 0.76
A three-year follow-up study of psoriasis patients treated with low dosages of etretinate orally and corticosteroids topically. Acta Derm Venereol (1982) 0.76
Xanthoma types in relation to the type of hyperlipoproteinemia. Nutr Metab (1973) 0.76
Xanthomatosis and other clinical findings in patients with elevated levels of very low density lipoproteins. Br J Dermatol (1979) 0.76
A clinical trial with hydrocortisone butyrate cream in eczema. Br J Dermatol (1973) 0.76
Xanthomata in primary hyperlipoproteinemia. A classification based on the lipoprotein pattern of the blood. Arch Dermatol (1969) 0.76
Hydrocortisone butyrate penetration through epidermis in vitro. Influence of vehiculum, connectration in the vehiculum, and the amount applied. Arch Dermatol Forsch (1972) 0.75
Letter: Side effects of clobetasone butyrate. Br Med J (1975) 0.75
[Xanthomas and hyperlipoproteinemias]. Ned Tijdschr Geneeskd (1977) 0.75
[Diagnosis of a malignant melanoma]. Ned Tijdschr Geneeskd (1973) 0.75
[The administration of corticosteroid ointments and creams]. Ned Tijdschr Geneeskd (1986) 0.75
Letter: Intertriginous xanthomas. Arch Dermatol (1974) 0.75
[The dosage of externally-applied corticosteroids in dermatology]. Ned Tijdschr Geneeskd (1984) 0.75
Distribution of various forms of xanthomata in three types of primary hyperlipoproteinemia. Dermatologica (1968) 0.75
[Xanthomatosis]. Ned Tijdschr Geneeskd (1967) 0.75
Comparison of two application schedules for clobetasol 17 propionate. Acta Derm Venereol (1982) 0.75
[Essential hyperlipoproteinemia]. Arch Belg Dermatol Syphiligr (1967) 0.75
Treatment of the diseases of the dermis. Arch Belg Dermatol Syphiligr (1973) 0.75
[Pellagroid syndrome in a patient treated with isoniazid]. Arch Belg Dermatol Syphiligr (1969) 0.75
[Dandruff]. Ned Tijdschr Geneeskd (1986) 0.75
Pediculosis therapy. J Am Acad Dermatol (1983) 0.75
Recurrent fibrosarcoma of the skin preceded by inflammation. Arch Chir Neerl (1973) 0.75
[Letter: Secundary luetic hepatitis]. Ned Tijdschr Geneeskd (1975) 0.75
Primary hyperlipoproteinemia in xanthomatosis. Clin Chim Acta (1976) 0.75
[Paget's disease of the breast]. Ned Tijdschr Geneeskd (1970) 0.75
Heredity in primary hyper-beta-lipoproteinemia with concomitant xanthomata. Report on three kindreds with presumably six homozygotes. Acta Med Scand (1970) 0.75
[Side effects of externally applied corticosteroids]. Ned Tijdschr Geneeskd (1968) 0.75
[Fungus infections from domestic animals and pets]. Ned Tijdschr Geneeskd (1977) 0.75
[Drugs against foot fungi]. Ned Tijdschr Geneeskd (1986) 0.75
Radiation therapy in dermatologic training centers. J Am Acad Dermatol (1987) 0.75
[Clindamycin in acne vulgaris]. Ned Tijdschr Geneeskd (1976) 0.75
Chemexfoliation: indications and cautions. J Am Acad Dermatol (1988) 0.75
Robert D. G. Ph. Simons--12 March 1909--28 November 1966. Dermatol Int (1967) 0.75
[Skin tuberculosis]. Ned Tijdschr Geneeskd (1972) 0.75
[Acne vulgaris]. Ned Tijdschr Geneeskd (1974) 0.75
[Experience with photochemotherapy with 8-methoxypsoralene by mouth and long-wave ultraviolet light (PUVA-treatment) in psoriasis]. Ned Tijdschr Geneeskd (1978) 0.75
Machiel K. Polano, M.D. J Am Acad Dermatol (1986) 0.75
[Melanomas]. Ned Tijdschr Geneeskd (1966) 0.75
Combined treatment of psoriasis with a new aromatic retinoid (Tigason) in low dosage orally and triamcinolone acetonide cream topically: a double-blind trial. Br J Dermatol (1980) 0.75
[Methotrexate treatment of psoriasis]. Ned Tijdschr Geneeskd (1974) 0.75
[Corticosteroids in dermatology]. Ned Tijdschr Geneeskd (1977) 0.75